All Stories

  1. A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease
  2. Self-Management Techniques in IBD
  3. Hypnosis for the esophagus
  4. Web-based interventions for ulcerative colitis and Crohn's disease: systematic review and future directions
  5. Disease-related pregnancy concerns and reproductive planning in women with inflammatory bowel diseases
  6. Mo1141 The Feasibility and Acceptability of Esophageal-Directed Hypnotherapy for Functional Heartburn
  7. Su1388 Stigmatizing Beliefs Toward the Irritable Bowel Syndrome and Inflammatory Bowel Disease
  8. Mo1294 Body Dissatisfaction and Disordered Eating in GI Patients: A Comparison of Functional Bowel Disorders, Inflammatory Bowel Disorders, and Esophageal Disorders
  9. 765 Symptom Reporting Among PPI Non Responders May Be Driven by Esophageal Hypervigilance and Not Reflux Phenotype
  10. Sa1259 The Impact of Hormonal Contraceptives on Inflammatory Bowel Disease Symptoms, Vaginal Bleeding, and Ovulation: A Pilot, Prospective Cohort Study
  11. Tu1272 Psychological Characteristics and Daily Abdominal Pain but Not Disease Type or Severity Predicted Medical Cannabis Use in IBD
  12. Mo1913 Reflux Associated With Symptoms: Does the Impedance Pattern Matter?
  13. Su1371 Non-Traumatic Stressful Events At the Time of Abdominal Pain Onset Is a Marker of Current Psychological but Not GI Health in More Severe IBS Patients
  14. Su1370 Diagnostic Accuracy of a Brief IBS Screener (4-IBS) for Use in Busy GI Practices
  15. Mo1271 Age Moderates the Relationship Between Medical Comorbidities and Distress in IBS Patients
  16. Mo1119 Detection of Reflux Mechanisms in PPI Non-Responder Patients: Post Prandial High Resolution Impedance Manometry (HRIM) Study
  17. Mo1912 Phenotypes of PPI Non-Responders Using Esophageal pH-Impedance Monitoring: How Are They Different?
  18. The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult Gastroenterologist
  19. The potential role of behavioral therapies in the management of centrally mediated abdominal pain
  20. The Impact of Hormonal Contraception on Disease-related Cyclical Symptoms in Women with Inflammatory Bowel Diseases
  21. Burnout in Gastroenterologists and How to Prevent it
  22. Development of a Self-Efficacy Scale for Adolescents and Young Adults With Inflammatory Bowel Disease
  23. Tu1987 Behavioral Treatment for Functional Esophageal Complaints
  24. Mo1865 Treatment Adherence in the Eosinophilic Gastrointestinal Disorders
  25. Sa1094 Mental Health Provider's Use of Psychological Treatments for Gastrointestinal Conditions
  26. Mo1863 Does Dietary Treatment for Eosinophilic Gastrointestinal Disorders Impact Health Related Quality of Life?
  27. Mo1862 Illness Stigma Perception in the Eosinophilic Gastrointestinal Disorders (EGIDs)
  28. Mo1864 Healthcare Utilization and Health Related Quality of Life in the Eosinophilic Gastrointestinal Disorders
  29. Mo1866 Internalized Stigma and Stigma Resistance in the Eosinophilic Gastrointestinal Disorders (EGIDs)
  30. Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey
  31. Mo1082 The Effect of Hormonal Contraceptives on Menstrual-Related Inflammatory Bowel Disease Symptoms
  32. Sa1083 Disease-Related Pregnancy Concerns and Reproductive Planning in Women With Inflammatory Bowel Disease
  33. Su1089 The Effects of IBD Patient Self Management Practices on IBD Flares and Patient Outcomes
  34. 894 Preliminary Development of a Self-Efficacy Scale for Adolescents and Young Adults With Inflammatory Bowel Disease
  35. Su1090 Fertility-Related Knowledge in Women With Inflammatory Bowel Diseases
  36. Su1526 When the Diagnosis Is Pancreatic Cancer: an Analysis of Coping Strategies Among Endosonographers
  37. 1049 "Breaking the Bad News": a Survey of Practice Patterns in Disclosing a Pancreatic Cancer Diagnosis Amongst US Endosonographers
  38. Sa1191 Modeling Health Care Utilization in Irritable Bowel Syndrome Patients: Distinguishing Factors That Influence the Decision to Consult a Doctor From Those That Influence Frequency of Doctor Visits
  39. Su2078 Grey Matter Alterations in Medial Prefrontal Cortex Show Negative Associations With Subjective Reports of Worry in IBS Patients
  40. Sa1830 Efficacy, Durability and Safety of Radiofrequency Ablation for Nondysplastic Barrett's Esophagus At a University Referral Center
  41. Tu1343 Recurrence of Intestinal Metaplasia Is Rare Following Endoscopic Eradication Therapy (EET) of Barrett's Esophagus Coupled With Effective Reflux Control: a Single Center Prospective Durability Study
  42. 1039 A Multicenter Prospective Randomized Controlled Cross-Over Trial Comparing Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) for Pancreatic and Non-Pancreatic Masses
  43. Psychological Treatment of Irritable Bowel Syndrome
  44. Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases
  45. Addition of Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration and On-Site Cytology to EUS-Guided Fine Needle Biopsy Increases Procedure Time but Not Diagnostic Accuracy
  46. Radiofrequency ablation for refractory gastric antral vascular ectasia (with video)
  47. Type, Rather Than Number, of Mental and Physical Comorbidities Increases the Severity of Symptoms in Patients With Irritable Bowel Syndrome
  48. Multicultural considerations in the diagnosis and management of irritable bowel syndrome
  49. Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome
  50. Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome
  51. Sa1337 Esophageal Hypervigilance: A Construct for Reflux and Dysphagia Symptoms Based on Patient Reported Outcomes
  52. Tu2063 IBS Symptom Severity Subtypes and Their Relationships With Psychosocial Factors: Improving the Sensitivity and Meaning of Patient Reported Outcomes
  53. Sa1087 Documentation of Reproductive Health Counseling and Contraception in Women With Inflammatory Bowel Disease
  54. Tu1795 The Role of Visceral Sensitivity, Psychological Distress, and Manometric Parameters in Patients With Reflux Symptoms
  55. Sa1329 Negative Aspects of Close Relationships Are More Strongly Associated With Symptom Burden of IBS Than Supportive Personal Relationships: Increasing the Precision of the Biopsychosocial Model
  56. 571 Type, Not Number, of Mental-Physical Comorbidities Increases the Severity of GI Symptoms in Patients With More Severe Irritable Bowel Syndrome
  57. Sa1330 Prevalence, Severity, and Predictors of Self-Reported Fatigue in Patients With Moderate to Severe IBS
  58. Sa1326 Psychosocial Predictors of Self Ratings of Health in Moderate to Severe IBS Patients: What's Involved in Feeling Healthy Besides the Severity of GI Symptoms?
  59. Sa1334 Testing the Relationship Between Psychological Factors and Post Prandial Symptoms in Moderate to Severe IBS Patients: Are We Approaching the Boundaries of the Biopsychosocial Model?
  60. Rapid On-Site Evaluation of Endoscopic Ultrasound Core Biopsy Specimens Has Excellent Specificity and Positive Predictive Value for Gastrointestinal Lesions
  61. The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
  62. Gastrointestinal Diseases
  63. Increased Risk for Persistent Intestinal Metaplasia in Patients With Barrett's Esophagus and Uncontrolled Reflux Exposure Before Radiofrequency Ablation
  64. Su1135 Validity, Usability, and Acceptability of the Eosinophilic Esophagitis Quality of Life Scale for Adults (EoE-QOL-A)
  65. Tu1061 Influence of Self-Management Interventions on Health Care Utilization in Patients With Gastrointestinal Conditions
  66. Sa1471 The Overutilization of Abdominal Computed Tomography for the Evaluation of Acute Pancreatitis
  67. 31 How Accurate Do IBS Patients Recall Past Abdominal Pain Intensity, Stool Frequency, and Stool Consistency?: A Comparison of Real Time Versus End-of-Week Symptom Ratings
  68. Sa1409 Additive and Interaction Effects of Medical and Mental Comorbidities on Health Outcomes in a Sample of Severely Affected IBS Patients From Two Tertiary Care Clinics
  69. Optimizing Management of Crohnʼs Disease Within a Project Management Framework: Results of A Pilot Study§
  70. Qualitative Assessment of Patient-reported Outcomes in Adults With Eosinophilic Esophagitis
  71. Increased Levels of Stress and Burnout Are Related to Decreased Physician Experience and to Interventional Gastroenterology Career Choice: Findings From a US Survey of Endoscopists
  72. Friends, Alcohol, and a Higher Power
  73. Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome
  74. Behavioral interventions may prolong remission in patients with inflammatory bowel disease
  75. The role of self-efficacy in inflammatory bowel disease management
  76. Psychological Co-morbidities of Irritable Bowel Syndrome
  77. Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease†
  78. S1054 Preliminary Results From the Ulcerative Colitis Relapse Prevention Study (UCRPT)
  79. M1053 From Perceptions to Beliefs: Internalized Stigma in Inflammatory Bowel Disease (IBD) Patients
  80. M1142 Hypnotically-Assisted Relaxation Therapy to Treat Globus Sensation: A Pilot Study
  81. S1081 Patient Reported Outcomes in Adults With Eosinophilic Esophagitis
  82. M1055 Preliminary Evidence Supporting a Framework of Psychological Adjustment to IBD: Results From a Pilot Study
  83. M1056 Assessing Disease Acceptance in a Sample of Patients With IBD: Preliminary Psychometrics of the Digestive Disease Acceptance Questionnaire (DDAQ)
  84. M1057 The Role of Self-Efficacy in Inflammatory Bowel Disease Management: Validation of a Disease-Specific Measure
  85. Rapid Response to Cognitive Behavior Therapy Predicts Treatment Outcome in Patients With Irritable Bowel Syndrome
  86. T1413: Increased Levels of Job-Related Stress and Burnout in Interventional Gastroenterologists (IGEs): Findings From a U.S. Survey
  87. Considering the Necessity of a Very Low Carbohydrate Diet on Diarrhea-Predominant Irritable Bowel Syndrome
  88. Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies
  89. Impact of perceived stigma on inflammatory bowel disease patient outcomes
  90. S1060 Perceived Stigma As a Predictor of Inflammatory Bowel Disease (IBD) Patient Concerns
  91. W1866 Examining the Relationship Between Esophageal Symptoms and Psychological Distress: A Pilot Study
  92. W1869 Development of Esophageal Symptoms Questionnaire (ESQ) for Assessment of Globus Sensation: Preliminary Findings
  93. Development and initial validation of a measure of perceived stigma in irritable bowel syndrome
  94. M1241 Language Analysis and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease
  95. M1252 Eating Habits and Dietary Composition of Patients with FBD: Preliminary Data from the Bingeing and Eating in Digestive Diseases Study (BEDDS)
  96. Functional Abdominal Pain in Adolescence: A Biopsychosocial Phenomenon
  97. Reconsidering the methodology of “stress” research in inflammatory bowel disease
  98. Multicenter Study of Gastroenterologistsʼ Ability to Identify Anxiety and Depression in a New Patient Encounter and its Impact on Diagnosis
  99. T1060 Perceived Stigma in IBD: Generalizability of the IBS Perceived Stigma Scale (PSS-IBS) and the Role of Stigma in Psychosocial Function
  100. W1074 Determinants of Bloating Severity: Symptomatic and Psychosocial Factors Influencing the Impactfullness of Bloating
  101. Impact of sleep disturbances in inflammatory bowel disease
  102. Quality of Life in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome Differs Between Subjects Recruited from Clinic or the Internet
  103. Feasibility and Acceptability of Gut-Directed Hypnosis on Inflammatory Bowel Disease:A Brief Communication
  104. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome
  105. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy
  106. Towards A Better Understanding of Anxiety in Irritable Bowel Syndrome: A Preliminary Look at Worry and Intolerance of Uncertainty
  107. Towards A Better Understanding of Anxiety in Irritable Bowel Syndrome: A Preliminary Look at Worry and Intolerance of Uncertainty
  108. A Behavioral Group Treatment Program for Menopausal Hot Flashes: Results of a Pilot Study
  109. Hot Flash, Hot Topic: Conceptualizing Menopausal Symptoms From a Cognitive-Behavioral Perspective
  110. The role of childhood abuse in Axis I and Axis II psychiatric disorders and medical disorders of unknown origin among irritable bowel syndrome patients
  111. Irritable Bowel Syndrome
  112. Early abuse, psychiatric diagnoses and irritable bowel syndrome
  113. Treatment-related changes in cardiovascular reactivity to trauma cues in motor vehicle accident-related PTSD
  114. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study
  115. Gender differences in psychological distress among patients with irritable bowel syndrome
  116. Irritable Bowel Syndrome